EIPICO is the Leading Egyptian Pharmaceutical Company, in Production, by Units. It produces 400 Pharmaceutical Products covering 25 therapeutic classes and it is the Major Provider of Antibiotics, Lyophilized products and Spansule Capsules, to the Egyptian market.
Read more
EIPICO provides High Quality Pharmaceutical Products at reasonable prices, thus assisting human healthcare improvement, both domestically and internationally.
EIPICO is ranked Number 1 in Egyptian Exports of Pharmaceutical Products, capturing 26% of Egypt’s Total Exports of Pharmaceutical Products, by Value. Exports are to European, African, Asian, Latin American, and CIS countries.
Biotechnology
EIPICO has the First Biotechnology and Genetic Engineering Research Center in Egypt.
Track and Trace
EIPICO implements a Track and Trace Program based on GS1 DataMatrix, the most widely used identification system worldwide, to ensure patient safety and enhance supply chain efficiency.
Global Accreditation
EIPICO has been accredited ISO Certificates besides Certificates from European, African, and Asian Health Authorities.
Ophthalmic Products
EIPICO is ranked Number 1 in the Egyptian Ophthalmic Market, by Units.
Cuba's Minister of Health visits EIPICO Factories
"EIPICO" affirms its superiority for the Egyptian pharmaceutical market in the first half of 2022.
EIPICO in cooperation with the Alliance of Greenmea & E L Square enter the era of digital transformation in pharmaceutical production " EIPICO pharma 4.0 project "
EIPICO is raising the awareness about pharmacovigilance among medical professionals and encouraging them to report any side effects encountered with its products.
EIPICO recruits and hires high-quality, self-motivated and enthusiastic personnel after whom it cares for, as its employees, as regards their health, safety, and welfare.
EIPICO is committed to its social responsibility. It has contributed to the "100 Million Healthy Lives" National Campaign aiming at elimination of hepatitis C virus (HCV) as a public health threat.